Latest Breaking News On - Nemoursai dupont - Page 1 : comparemela.com

Synaptogenix Provides Corporate Update and Outlines Potential Business Opportunities

/PRNewswire/ Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics.

New leadership for the College of Health Sciences

William Farquhar named next dean of College of Health Sciences

Health Sciences dean search underway

Search advisory committee appointed to identify next College of Health Sciences dean

MS Trials Being Planned Into Bryostatin-1, Molecule to Protect Synapses

Synaptogenix Moves Forward with Clinical Development Plans for Bryostatin-1 as a Treatment for Multiple Sclerosis

/PRNewswire/ Synaptogenix, Inc. (Nasdaq: SNPX), a clinical-stage biopharmaceutical company developing regenerative therapeutics for neurodegenerative.